Nuwellis, Inc. (NUWE) Research

Nuwellis, Inc. is a medical device firm specializing in the creation, production, and commercialization of devices for ultrafiltration therapy. Its primary offerings, the Aquadex FlexFlow and Aquadex SmartFlow systems, are specifically designed to address fluid overload in patients who have not responded adequately to diuretic medications. The Aquadex FlexFlow system, for instance, consists of a main console, a single-use blood circuit, and a catheter. The company distributes its solutions to hospitals and clinics through its dedicated salesforce within the United States. Internationally, its products are available via a network of independent specialty distributors in numerous countries, including Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. Founded in 1999, and based in Eden Prairie, Minnesota, the company adopted the name Nuwellis, Inc. in April 2021, having previously operated as CHF Solutions, Inc.

Open Nuwellis, Inc. (NUWE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.